Phase II Study of Paclitaxel, Carboplatin, and Cetuximab as First Line Treatment, for Patients with Advanced Non-small Cell Lung Cancer (NSCLC): Results of OPN-017
Borghaei, Hossein, Langer, Corey J., Millenson, Michael, Ruth, Karen J., Litwin, Samuel, Tuttle, Holly, Seldomridge, Judie Sylvester, Rovito, Marc, Mintzer, David, Cohen, Roger, Treat, JosephVolume:
3
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1097/JTO.0b013e318189f50e
Date:
November, 2008
File:
PDF, 192 KB
english, 2008